{
    "clinical_study": {
        "@rank": "97277", 
        "arm_group": {
            "arm_group_label": "Group A", 
            "arm_group_type": "Experimental", 
            "description": "ROX Anastomic Coupler System (ACS) + continuing standard antihypertensive medications"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the safety and performance of the ROX Anastomotic\n      Coupler System (ACS) in patients with severe hypertension."
        }, 
        "brief_title": "A Multicenter Study to Evaluate the ROX Anastomotic Coupler System (ACS) In Patients With Severe Hypertension", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of severe hypertension must be made on the basis of current findings,\n             medical history, and physical examination\n\n        Exclusion Criteria:\n\n          -  Any serious medical condition that may adversely affect the patient's safety, limit\n             the subject's ability to participate in the study, comply with follow-up requirements\n             or impact the scientific integrity of the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01682057", 
            "org_study_id": "RH-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group A", 
                "description": "The ROX Anastomic Coupler (ACS) will be used to create an arteriovenous fistula in the iliac region (between the iliac artery and vein).", 
                "intervention_name": "ROX ANASTOMOTIC COUPLER SYSTEM (ACS)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Group A", 
                "intervention_name": "ROX Anastomotic Coupler System (ACS)", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "High Blood Pressure", 
            "Hypertension", 
            "Resistant Hypertension"
        ], 
        "lastchanged_date": "June 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Brussels", 
                    "country": "Belgium", 
                    "zip": "1090"
                }, 
                "name": "Universitair Ziekenhuis Brussel"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Non-Randomized, Open Label, Multi-Center Study to Evaluate the ROX Anastomotic Coupler System (ACS) in Patients With Severe Hypertension", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in mean office SBP at six months as compared to Baseline", 
            "measure": "Change in mean office SBP", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01682057"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Change in mean office DBP at six months as compared to Baseline", 
            "measure": "Change in mean office DBP", 
            "safety_issue": "No", 
            "time_frame": "Change in mean office DBP six months as compared to Baseline"
        }, 
        "source": "ROX Medical, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ROX Medical, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}